Your browser doesn't support javascript.
loading
Association between ethnicity, language and metformin prescriptions in U.S. community health center patients with diabetes.
Ezekiel-Herrera, David; Marino, Miguel; Lucas, Jennifer A; Datta, Roopradha; Aceves, Benjamín; Boston, Dave; Heintzman, John.
Afiliación
  • Ezekiel-Herrera D; Oregon Health & Science University Department of Family Medicine, Portland, OR, USA. Electronic address: ezekiel@ohsu.edu.
  • Marino M; Oregon Health & Science University Department of Family Medicine, Portland, OR, USA.
  • Lucas JA; Oregon Health & Science University Department of Family Medicine, Portland, OR, USA.
  • Datta R; Oregon Health & Science University Department of Family Medicine, Portland, OR, USA.
  • Aceves B; San Diego State University School of Public Health, San Diego, CA, USA.
  • Boston D; OCHIN, Inc., Portland, OR, USA.
  • Heintzman J; Oregon Health & Science University Department of Family Medicine, Portland, OR, USA.
Prev Med ; 185: 108025, 2024 Aug.
Article en En | MEDLINE | ID: mdl-38834161
ABSTRACT

BACKGROUND:

Metformin treatment is a recommended first-line medication for patients with type 2 diabetes. Latino patients are subject to factors that may modify their level of diabetes care, including medication prescription. We evaluated the odds of and times to metformin prescription among non-Latino whites, English-preferring Latinos, and Spanish-preferring Latinos with diabetes.

METHODS:

We constructed a retrospective cohort of 154,368 adult patients from 835 community health centers (CHCs) across 20 states who were diagnosed with diabetes during the study. Patients were from non-Latino white, English-preferring Latino, and Spanish-preferring Latino ethnic/language groups. We modeled adjusted odds of metformin prescription and adjusted hazards (time-to-event) of metformin prescription after diabetes diagnosis and high hemoglobin A1c (HbA1c > 9) test results.

RESULTS:

English-preferring Latinos had similar odds of metformin prescription (Odds Ratio (OR) = 1.01 (95% CI = 0.93, 1.09)), slightly lower time to metformin prescription after diabetes diagnosis (Hazard Ratio (HR) = 1.06(95% CI = 1.04, 1.09)), and similar time to metformin prescription after a high HbA1c result (HR = 1.04 (0.99, 1.09)) compared to non-Latino whites. Spanish-preferring Latinos had higher odds of metformin prescription (OR) = 1.42 (95% CI = 1.33, 1.52), and less time to prescription after diabetes diagnosis (HR = 1.18 (1.15, 1.20)) and after a high HbA1c result (HR = 1.15 (1.11, 1.20)).

CONCLUSIONS:

Our analysis of metformin prescription patterns among non-Latino whites, English-preferring Latinos, and Spanish-preferring Latinos did not suggest a lower or slower tendency to prescribe metformin in Latino patients. Understanding disparities in diabetes diagnosis may require further investigation of medication adherence barriers, diet and exercise counseling, and multi-level influences on diabetes outcomes in Latino patients.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Prescripciones de Medicamentos / Diabetes Mellitus Tipo 2 / Hipoglucemiantes / Lenguaje / Metformina Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Prev Med / Prev. med / Preventive medicine Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Prescripciones de Medicamentos / Diabetes Mellitus Tipo 2 / Hipoglucemiantes / Lenguaje / Metformina Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Prev Med / Prev. med / Preventive medicine Año: 2024 Tipo del documento: Article